 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gagnants
Le titre Molina Healthcare (NYSE:MOH) a grimp mercredi de 24,25% 503,11 dollars lors de la session after-market.
L'action Evoke Pharma (NASDAQ:EVOK) a grimp de 18,54% 0,76...

12 titres de soins de sant  en mouvement lors de la session apr s-cl ture le 13/03/2024

Galecto, Inc. (NASDAQ:GLTO  Free Report)  Leerink Partnrs boosted their FY2023 earnings per share (EPS) estimates for Galecto in a report released on Monday, February 5th. Leerink...

Galecto, Inc. Expected to Post FY2023 Earnings of ($1.56) Per Share (NASDAQ:GLTO)

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Is Galecto (NASDAQ:GLTO) In A Good Position To Invest In Growth?

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3, lysyl oxidase-like 2, and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Volume (M)	76,566.00
52-Wk High	$3.70
52-Wk Low	$0.50

GLTO Galecto Inc

About

Feed

News

Sentiment

Earnings

Fundamentals